WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006088576) POLYPEPTIDE FORMULATIONS AND METHODS FOR MAKING, USING AND CHARACTERIZING THEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/088576    International Application No.:    PCT/US2006/001048
Publication Date: 24.08.2006 International Filing Date: 12.01.2006
IPC:
G01N 33/15 (2006.01), A61K 47/00 (2006.01), G01N 30/02 (2006.01), C12Q 1/00 (2006.01), A61K 38/44 (2006.01), G01N 30/06 (2006.01), G01N 27/30 (2006.01)
Applicants: MEDTRONIC MINIMED, INC. [US/US]; 18000 Devonshire Street, Northridge, California 91325-1219 (US) (For All Designated States Except US).
GULATI, Poonam, S. [US/US]; (US) (For US Only).
CHATTARAJ, Sarnath [IN/US]; (US) (For US Only).
MINNOOR, Elango [IN/US]; (US) (For US Only).
LEVIN, Eugene [US/US]; (US) (For US Only).
ZHU, Xiao [US/US]; (US) (For US Only).
VAN ANTWERP, William, Peter [US/US]; (US) (For US Only)
Inventors: GULATI, Poonam, S.; (US).
CHATTARAJ, Sarnath; (US).
MINNOOR, Elango; (US).
LEVIN, Eugene; (US).
ZHU, Xiao; (US).
VAN ANTWERP, William, Peter; (US)
Agent: WOOD, William, J.; GATES & COOPER LLP, SUITE 1050, 6701 Center Drive West, Los Angeles, California 90045 (US)
Priority Data:
11/060,255 17.02.2005 US
Title (EN) POLYPEPTIDE FORMULATIONS AND METHODS FOR MAKING, USING AND CHARACTERIZING THEM
(FR) FORMULATIONS DE POLYPEPTIDES ET LEURS PROCEDES DE FABRICATION, D'UTILISATION ET DE CARACTERISATION
Abstract: front page image
(EN)Embodiments of the invention include polypeptide formulations and methods for making, using and characterizing them. Embodiment of the invention include stabilized polypeptide formulations, for example stable glucose oxidase formulations that can be used with glucose sensors used in the management of diabetes. Another embodiment of the invention includes methods to characterize the concentration of nonionic surfactants in stabilized polypeptide formulation for example stable insulin formulations that can be used in the treatment of diabetes.
(FR)Des modes de réalisation de l'invention concernent des formulations de polypeptides et des procédés de fabrication, utilisation et caractérisation desdites formulations. Le mode de réalisation de l'invention concerne des formulations de polypeptides stabilisées, notamment des formulations d'oxydase glucose stable, susceptibles d'être utilisées avec des capteurs de glucose utilisés dans la gestion du diabète. Un autre mode de réalisation de l'invention concerne des procédés de caractérisation de la concentration de tensioactifs non ioniques dans une formulation de polypeptides stabilisée, notamment des formulations d'insuline stables, susceptibles d'être utilisées dans le traitement du diabète.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)